Biovail Laboratories has signed an agreement with Santhera Pharmaceuticals, entitling Biovail to the US and Canadian rights to develop and commercialize fipamezole (also known as JP-1730), for the ...

Here are some formerly rockstar businesses that ended up as turnaround candidates, their tale of woes and their often unhappy conclusions This advertisement has not loaded yet, but your article ...